Editorials
The influence of big pharma
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7496.855 (Published 14 April 2005) Cite this as: BMJ 2005;330:855Related articles
- Editor's Choice Published: 14 April 2005; BMJ 330 doi:10.1136/bmj.330.7496.0-g
- Mixed Messages Published: 24 December 1994; BMJ 309 doi:10.1136/bmj.309.6970.1734
- Paper Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.1171
- Editorial Published: 09 March 2006; BMJ 332 doi:10.1136/bmj.332.7541.562
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinsons in an international setting
- Treating refractory epilepsy in adults
- Drug safety and regulation